Target single and double sanction badge users Expected effectiveness of covering various types of cell culture media Ajinomoto Genexine’s cell culture medium brand CELLiST (CELLiST) announced on the 24th that it has launched ‘AminoSupplement Cys1/Cys2’. CELLiST plans to construct and supply a product lineup that can cover various types of cell culture media by dividing […]

ROCKVILLE, Md. — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced Douglas J. Swirsky has been appointed as the Company’s Chief Financial Officer, effective immediately. Mr. Swirsky is a […]

WALTHAM, Mass. & SAN FRANCISCO — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s […]

Life sciences veteran will continue to drive commercial excellence, build on company’s legacy to propel future strategic growth CORALVILLE, Iowa — Global genomics solutions provider Integrated DNA Technologies (IDT) announced it has appointed Linda De Jesus as vice president and general manager, global head of commercial, adding a new leader to the company’s executive team. De Jesus brings […]

Atrandi Biosciences Secures Funding and Advances Global Commercialization of Next-Gen Single Cell Analysis Technology VILNIUS, Lithuania and DENVER, CO – Backed by international investors, Atrandi Biosciences is establishing a direct team to support customers in the U.S. and advancing the global commercialization of its breakthrough microfluidic and single-cell analysis technologies. Following a €4.5 million funding round […]

LAUSANNE, Switzerland – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, announced today that it has completed CHF 40M in Series D1 funding. The round was led by Ernst-Göhner Stiftung Beteiligungen (EGSB), and existing investors PHC Holdings Corporation, Swiss Entrepreneurs Fund, OCCIDENT, and Redalpine participated. The funding includes a EUR […]

We are excited to announce the relaunch of our high-precision ion channel screening platform Dynaflow® Resolve. With Dynaflow Resolve, you can study any ion channel in any cell in any patch-clamp configuration and perform dose-response assays with high accuracy and reproducibility. Dynaflow Resolve has been part of Fluicell’s product portfolio since 2017 and is used by biotech […]

Brown Gibbons Lang & Company (BGL) is a leading investment banking and financial advisory firm, is pleased to announce the sale of lino Biotech, a leading biosensor company and the world’s only provider of Focal Molography, to Miltenyi Biotec, a global biotech company based in Germany. BGL’s Diagnostics, Research Tools & Medical Devices investment banking […]

AMSBIO is pleased to announce the launch of Extragel, a like-for-like replacement for Matrigel™, GeltrexTM and CultrexTM Basement Membrane Extract (BME). Available ex-stock, with overnight shipment, Extragel is a reconstituted matrix hydrogel formed by basement membrane components extracted from mouse tumor tissues which are rich in extracellular matrix proteins. Designed to be used undiluted or diluted to a specific protein concentration, Extragel is proven to […]

PhenomeX to begin trading under symbol (NASDAQ: CELL) EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health. The newly combined […]